InMed Pharmaceuticals, Inc.

InMed Pharmaceuticals, Inc.

InMed Pharmaceuticals, Inc.

Overview
Date Founded

1981

Headquarters

700 West Georgia Street,Suite 2500,Vancouver, BC V7Y 1B3

Type of Company

Public

Employees (Worldwide)

9

Industries

Pharmaceuticals
Biotechnology

Company Description

InMed Pharmaceuticals, Inc. engages in the development of cannabinoids drug design platform. Its product pipeline includes INM-750 for the treatment of epidermolysis bullosa and INM-085 for the treatment of glaucoma. The company was founded by Christopher Bogart and Craig D. Schneider on May 19, 1981 and is headquartered in Vancouver, Canada.

Contact Data
Trying to get in touch with decision makers at InMed Pharmaceuticals, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

President, Chief Executive Officer & Director

Chief Financial Officer & Corporate Secretary

Chief Technical Officer

Chief Business Officer

Senior Vice President, Clinical & Regulatory Affairs

Vice President-Chemistry, Manufacturing & Controls

Vice President-Preclinical Research & Development

Professional

Board of Directors

Chief Financial Officer & Treasurer at Molecular Templates, Inc.

Vice President of Corporate Finance & Investment Banking at Eli Lilly & Company

President, Chief Executive Officer & Director at InMed Pharmaceuticals, Inc.

Vice President, Global Alliance Management at Takeda Pharmaceutical Co., Ltd.

Paths to InMed Pharmaceuticals, Inc.
Potential Connections via
Relationship Science
You
InMed Pharmaceuticals, Inc.
Recent Transactions
Details Hidden

InMed Pharmaceuticals, Inc. issued . CAD Units Consisting of Common Share and Warrants - Bought Deal

Details Hidden

InMed Pharmaceuticals, Inc. issued CAD Units Consisting of Common Share and Warrants

Details Hidden

InMed Pharmaceuticals, Inc. purchases Biogen Sciences, Inc.

Transaction Advisors
Accountant

Advised onInMed Pharmaceuticals, Inc. purchases Eworldcentre.com from INToo Software Corp.

Escrow Agent

Advised onInMed Pharmaceuticals, Inc. issued . CAD Units Consisting of Common Share and Warrants - Bought Deal

Underwriter

Advised onInMed Pharmaceuticals, Inc. issued . CAD Units Consisting of Common Share and Warrants - Bought Deal

Advisors & Consultants
Scientific Advisor

Chief Scientific Officer & Director at Inception IBD, Inc.

Publicist

Senior Vice President, Investors Relations at Tiberend Strategic Advisors, Inc.

Publicist

Senior Account Executive at Tiberend Strategic Advisors, Inc.

Key Stats and Financials As of 2018
Market Capitalization
$89.5M
Total Enterprise Value
$81.8M
Earnings Per Share
$-0.06
Revenue
$0
Net Profit
$-8.52M
EBITDA
$-8.49M
Total Debt
$0
Total Equity
$27.1M
TEVNet Income
-9.6x
Debt TEV
0x
Suppliers
University of British Columbia Schools & Student Services | VANCOUVER, BRITISH COLUMBIA

The University of British Columbia (UBC), established in 1908, is one of Canada’s leading research universities and is consistently ranked among the top 40 in the world. The university attracts 54,000 students from across Canada and 140 countries around the world to two major campuses.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by InMed Pharmaceuticals, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of InMed Pharmaceuticals, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and InMed Pharmaceuticals, Inc..
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://relationshipscience.com/organization/inmed-pharmaceuticals-inc-69749
  • https://relationshipscience.com/organization/inmed-pharmaceuticals-inc-69749